S0819, “A Randomized, Phase III Study Comparing Carboplatin/Paclitaxel or Carboplatin/Paclitaxel/Bevacizumab with or without Concurrent Cetuximab in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC).
Gordan Srkalovic MD, PhD
Patient must have non small cell lung cancer, stage IV. Must be new or recurrent after surgery and or radiation.
Contact for Questions
Sparrow Cancer Center 800-968-5570